(18)F-FDG PET/CT Is an Early Predictor of Pathologic Tumor Response and Survival After Preoperative Radiochemotherapy with Bevacizumab in High-Risk Locally Advanced Rectal Cancer

There is an unmet need for predictive biomarkers of the clinical benefit of antiangiogenic drugs. The aim of the present study was to prospectively evaluate the value of (18)F-FDG PET/CT performed during and after preoperative chemoradiotherapy with bevacizumab for the prediction of complete patholo...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Nucl Med
Main Authors: Avallone, Antonio, Aloj, Luigi, Pecori, Biagio, Caracò, Corradina, De Stefano, Alfonso, Tatangelo, Fabiana, Silvestro, Lucrezia, Granata, Vincenza, Bianco, Francesco, Romano, Carmela, Di Gennaro, Francesca, Budillon, Alfredo, Petrillo, Antonella, Muto, Paolo, Botti, Gerardo, Delrio, Paolo, Lastoria, Secondo
Formato: Artigo
Idioma:Inglês
Publicado: Society of Nuclear Medicine 2019
Assuntos:
Oncology
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6836863/
https://ncbi.nlm.nih.gov/pubmed/30877175
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2967/jnumed.118.222604
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares